Literature DB >> 3385205

Mechanisms of partial renal infarct hypertension.

R A Norman1, P G Galloway, D J Dzielak, M Huang.   

Abstract

Contributions of both the renin-angiotensin and immune systems to the aetiology of renal infarct hypertension were examined in Sprague-Dawley rats. Partial renal infarction was produced by ligating and sectioning two out of three branches of the left renal artery. The right kidney remained intact. Renal infarction resulted in rapid development of stable hypertension. One week following infarction, the plasma renin activity (PRA) increased more than threefold. However, PRA returned to control levels 4 weeks after infarction. Chronic immunosuppressive therapy with cyclophosphamide at most only attenuated the development of renal infarct hypertension associated with this transient renin elevation. However, cyclophosphamide prevented the later maintenance phase of the hypertension, and could also completely reverse established infarct hypertension. Activation of the renin-angiotensin system plays a role in the onset of partial renal infarct hypertension, but an intact immune system is required for maintenance of the hypertension. It is hypothesized that immunological reactions against renal tissue maintain renal infarct hypertension.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3385205

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  14 in total

Review 1.  Renal inflammation, autoimmunity and salt-sensitive hypertension.

Authors:  Bernardo Rodríguez-Iturbe; Martha Franco; Edilia Tapia; Yasmir Quiroz; Richard J Johnson
Journal:  Clin Exp Pharmacol Physiol       Date:  2012-01       Impact factor: 2.557

Review 2.  Renal infiltration of immunocompetent cells: cause and effect of sodium-sensitive hypertension.

Authors:  Bernardo Rodriguez-Iturbe
Journal:  Clin Exp Nephrol       Date:  2010-02-19       Impact factor: 2.801

3.  Acute renal infarction: a case series.

Authors:  Marie Bourgault; Philippe Grimbert; Catherine Verret; Jacques Pourrat; Michel Herody; Jean Michel Halimi; Alexandre Karras; Zahir Amoura; Noémie Jourde-Chiche; Hassan Izzedine; Hélène François; Jean-Jacques Boffa; Aurélie Hummel; Pauline Bernadet-Monrozies; Denis Fouque; Florence Canouï-Poitrine; Philippe Lang; Eric Daugas; Vincent Audard
Journal:  Clin J Am Soc Nephrol       Date:  2012-11-30       Impact factor: 8.237

Review 4.  Infiltrating immune cells in the kidney in salt-sensitive hypertension and renal injury.

Authors:  David L Mattson
Journal:  Am J Physiol Renal Physiol       Date:  2014-07-09

Review 5.  Role of glomerular filtration rate in controlling blood pressure early in diabetes.

Authors:  Michael W Brands; Hicham Labazi
Journal:  Hypertension       Date:  2008-07-07       Impact factor: 10.190

Review 6.  Autoimmunity in the pathogenesis of hypertension.

Authors:  Bernardo Rodríguez-Iturbe; Héctor Pons; Yasmir Quiroz; Miguel A Lanaspa; Richard J Johnson
Journal:  Nat Rev Nephrol       Date:  2013-11-19       Impact factor: 28.314

7.  Spontaneous renal artery dissection with renal infarction.

Authors:  Sophie Renaud; Hélène Leray-Moraguès; Leila Chenine; Ludovic Canaud; Hélène Vernhet-Kovacsik; Bernard Canaud
Journal:  Clin Kidney J       Date:  2012-06

8.  Multiorgan with renal infarction following treatment of cerebral infarction.

Authors:  Ji Hee Kim; Chung Kang; Hyo Jeong Moon; Min Cheol Joo
Journal:  Ann Rehabil Med       Date:  2013-08-26

Review 9.  Immunity and Hypertension.

Authors:  Rong M Zhang; Kyle P McNerney; Amy E Riek; Carlos Bernal-Mizrachi
Journal:  Acta Physiol (Oxf)       Date:  2020-06-25       Impact factor: 6.311

10.  Hypertension and the Kidney: Reduced Kidney Mass Is Bad for Both Normotensive and Hypertensive Rats.

Authors:  Kyle Ware; Vedat Yildiz; Min Xiao; Ajay Medipally; Jessica Hemminger; Rachel Scarl; Anjali A Satoskar; Lee Hebert; Iouri Ivanov; Laura Biederman; Sergey V Brodsky
Journal:  Am J Hypertens       Date:  2021-11-20       Impact factor: 3.080

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.